Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

Zlokovic B.

Neurobiol Dis. 1997;4(1):23-6. Review. No abstract available.

PMID:
9258908
2.

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV.

Vascul Pharmacol. 2002 Jun;38(6):303-13.

PMID:
12529925
3.

Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels.

Iwamoto N, Nishiyama E, Ohwada J, Arai H.

Acta Neuropathol. 1997 Apr;93(4):334-40.

PMID:
9113198
4.

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.

Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L.

Nature. 1997 Oct 9;389(6651):603-6.

PMID:
9335500
5.

Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.

Butterfield DA, Griffin S, Munch G, Pasinetti GM.

J Alzheimers Dis. 2002 Jun;4(3):193-201. Review.

PMID:
12226538
6.

[Does acidosis in brain play a role in Alzheimer's disease?].

Pirchl M, Humpel C.

Neuropsychiatr. 2009;23(3):187-92. German.

PMID:
19703385
7.

Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.

Montalto MC, Farrar G, Hehir CT.

Ann N Y Acad Sci. 2007 Feb;1097:239-58. Review.

PMID:
17413026
8.

Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

Small DH, McLean CA.

J Neurochem. 1999 Aug;73(2):443-9. Review. No abstract available.

9.

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Uryu K, Laurer H, McIntosh T, Praticò D, Martinez D, Leight S, Lee VM, Trojanowski JQ.

J Neurosci. 2002 Jan 15;22(2):446-54.

10.

The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.

Kalaria RN.

Ann N Y Acad Sci. 1999;893:113-25. Review.

PMID:
10672233
11.

Amyloidosis and Alzheimer's disease.

Ghiso J, Frangione B.

Adv Drug Deliv Rev. 2002 Dec 7;54(12):1539-51. Review.

PMID:
12453671
12.

Cerebral Abeta amyloidosis and postmenopausal hormone deficiency: roles in the genesis of Alzheimer's disease.

Gandy S.

Hum Pathol. 2004 Mar;35(3):271-4. Review. No abstract available.

PMID:
15017581
13.
14.

Can deposition of amyloid be prevented in Alzheimer's disease?

Kisilevsky R.

Ann N Y Acad Sci. 1997 Sep 26;826:117-27. Review.

PMID:
9329685
15.

Pathological aging in Africans: a benign form of cerebral amyloidosis vs. pre-clinical Alzheimer's disease?

Dickson DW.

Brain Pathol. 1996 Apr;6(2):107-8. No abstract available.

PMID:
8737924
16.

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM.

Science. 2002 Mar 22;295(5563):2264-7.

17.

Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits.

Zatta P, Zambenedetti P, Stella MP, Licastro F.

J Alzheimers Dis. 2002 Feb;4(1):1-9.

PMID:
12214013
18.
19.

[Advances in molecular pathology of Alzheimer's disease].

Coria-Balanzat F.

Rev Neurol. 2006 Mar 1-15;42(5):306-9. Review. Spanish.

20.

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castaño EM, Frangione B.

Nat Med. 1998 Jul;4(7):822-6.

PMID:
9662374
Items per page

Supplemental Content

Support Center